Literature DB >> 13458666

Resistance of Plasmodium malariae to pyrimethamine (daraprim).

M D YOUNG.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/therapeutic use

Mesh：

Substances：

Year:  1957        PMID： 13458666     DOI： 10.4269/ajtmh.1957.6.621

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  4 in total

1.  CHANGING TIDES OF CHEMOTHERAPY OF MALARIA.

Authors:  L J BRUCE-CHWATT
Journal:  Br Med J       Date:  1964-03-07

2.  Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene.

Authors:  Nimol Khim; Saorin Kim; Christiane Bouchier; Magali Tichit; Frédéric Ariey; Thierry Fandeur; Pheaktra Chim; Sopheakvatey Ke; Sarorn Sum; Somnang Man; Arsène Ratsimbasoa; Rémy Durand; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  The development of pyrimethamine resistance by Plasmodium falciparum.

Authors:  R W BURGESS; M D YOUNG
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

4.  Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae.

Authors:  Naowarat Tanomsing; Mallika Imwong; Sasithon Pukrittayakamee; Kesinee Chotivanich; Sornchai Looareesuwan; Mayfong Mayxay; Christiane Dolecek; Tran Tinh Hien; Virgilio E do Rosario; Ana Paula Arez; Pascal Michon; Georges Snounou; Nicholas J White; Nicholas P J Day
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.